Reduction of Microalbuminuria by Blockers: Beyond Renin-Angiotensin System Blockade

Hypertension - United States
doi 10.1161/01.hyp.0000190586.07087.ca
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cardiovascular Risk Reduction With Renin-Angiotensin Aldosterone System Blockade

Nursing Research and Practice
2010English

Dual Blockade of the Renin-Angiotensin System With Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs)

British Journal of Clinical Pharmacology
Pharmacology
2011English

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2010English

Renin-Angiotensin System Blockade Improves Endothelial Dysfunction in Hypertension

Hypertension
Internal Medicine
2000English

Dual Renin-Angiotensin-Aldosterone System Blockade for Diabetic Kidney Disease

Current Diabetes Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences

Journal of Clinical Medicine
2015English

The Relentless Crumbling of the Renin-Angiotensin System (RAS)-blockade Halo

Annals of Translational Medicine
Medicine
2016English

Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers

JAMA Cardiology
Cardiovascular MedicineCardiology
2020English

Renin-Angiotensin System Blockade for the Risk of Cancer and Death

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy